SNMMI 2018 names outstanding contributors in nuclear medicine, molecular imaging

Melissa Rohman | | Health Imaging | Molecular Imaging
SNMMI

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) released its list of members recognized for outstanding dedication to and service in the fields of nuclear medicine and molecular imaging.

The list of honored individuals was originally announced during the 2018 SNMMI annual meeting in Philadelphia in June, according to an Aug. 13 SNMMI news release.  

Awards were given to professionals in nuclear medicine and molecular imaging who have helped advance the diagnosis and treatment of heart disease, cancer, neurological conditions, contributed to the advancement of women in medical imaging contributed to the advancement of women in medical imaging, radiopharmaceutical sciences and pediatric imaging, as well as those who have shown continual dedication to SNMMI.  

See the 2018 SNMMI’s entire list of outstanding contributors here.  

""
Melissa Rohman

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Related Content

Repurposed radiotracer lights up treatment-resistant tumors 'like a Christmas tree'
Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.